ЗначениеQ4, 24Q1, 25Q2, 25Всего обязательств39.55 M39.32 M39.81 MОбщий капитал-865 K-5.65 M-9.21 MВсего обязательств и собственного капитала38.68 M33.67 M30.6 MОбщий долг27.29 M33.57 M33.93 MЧистый долг5.38 M17.18 M20.28 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.